ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone

Study limitation reported by the research below: “The development cohort (n=145) is small and cognitively impaired (MCI/AD dementia), while the validation cohort (n=1,644) is cognitively unimpaired, making direct performance comparison across cohorts difficult and limiting applicability to populations bridging both groups.”

Papers